Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Plos One|June 21, 2016
Cortical Dopamine Transmission as Measured with the [11C]FLB 457 - Amphetamine PET Imaging Paradigm Is Not Influenced by COMT GenotypeRajesh Narendran, Divya Tumuluru, Maureen A May, et al.
Nuclear Medicine and Biology|June 29, 2002
Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonistYolanda Zea-Ponce, Lawrence S Kegeles, Ningning Guo, et al.
CNS Spectrums|March 5, 2004
Presence of irritability during depressive episodes in bipolar disorderThilo Deckersbach, Roy H Perlis, W Gordon Frankle, et al.
Synapse (New York, N.Y.)|August 10, 2004
Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studiesMark Slifstein, Raj Narendran, Dah-Ren Hwang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2003
Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophreniaNingning Guo, Dah-Ren Hwang, Ee-Sing Lo, et al.
Schizophrenia Bulletin|September 17, 2005
Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophreniaRaymond Y Cho, Judith M Ford, John H Krystal, et al.
Plos One|March 3, 2012
[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levelsW Gordon Frankle, Raymond Y Cho, N Scott Mason, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 11, 2008
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjectsW Gordon Frankle, Raymond Y Cho, Rajesh Narendran, et al.
The American Journal of Psychiatry|July 3, 2015
In vivo measurement of GABA transmission in healthy subjects and schizophrenia patientsW Gordon Frankle, Raymond Y Cho, Konasale M Prasad, et al.
Synapse (New York, N.Y.)|December 8, 2017
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxineW Gordon Frankle, Brigitte Robertson, Gary Maier, et al.
Pageof 14